ENTRY       D08903                      Drug
NAME        Dexlansoprazole (INN/USAN);
            Dexilant (TN)
PRODUCT     DEXILANT (Cardinal Health 107)
            DEXILANT (Takeda Pharmaceuticals America)
  GENERIC   DEXLANSOPRAZOLE (A-S Medication Solutions)
            DEXLANSOPRAZOLE (A-S Medication Solutions)
            DEXLANSOPRAZOLE (Golden State Medical Supply)
            DEXLANSOPRAZOLE (Par Pharmaceutical)
            DEXLANSOPRAZOLE (REMEDYREPACK)
            DEXLANSOPRAZOLE (TWI PHARMACEUTICALS)
            DEXLANSOPRAZOLE (TWI PHARMACEUTICALS)
FORMULA     C16H14F3N3O2S
EXACT_MASS  369.0759
MOL_WEIGHT  369.3615
CLASS       Gastrointestinal agent
             DG01975  Agents for peptic ulcer
              DG01646  Proton pump inhibitor (PPI)
            Metabolizing enzyme substrate
             DG01639  CYP2C19 substrate
             DG01633  CYP3A/CYP3A4 substrate
              DG02913  CYP3A4 substrate
            Metabolizing enzyme inhibitor
             DG01933  CYP2C19 inhibitor
REMARK      ATC code: A02BC06
            Product: D08903<US>
EFFICACY    Anti-ulcerative, Proton pump inhibitor
  DISEASE   Gastroesophageal reflux disease [DS:H01602]
COMMENT     Benzimidazole derivative
TARGET      ATP4 [HSA:495 496] [KO:K01542 K01543]
  PATHWAY   hsa04966(495+496)  Collecting duct acid secretion
            hsa04971(495+496)  Gastric acid secretion
METABOLISM  Enzyme: CYP2C19 [HSA:1557], CYP3A4 [HSA:1576]
INTERACTION CYP inhibition: CYP2C19 [HSA:1557]
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             A ALIMENTARY TRACT AND METABOLISM
              A02 DRUGS FOR ACID RELATED DISORDERS
               A02B DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD)
                A02BC Proton pump inhibitors
                 A02BC06 Dexlansoprazole
                  D08903  Dexlansoprazole (INN/USAN) &lt;US&gt;
            USP drug classification [BR:br08302]
             Gastrointestinal Agents
              Proton Pump Inhibitors
               Dexlansoprazole
                D08903  Dexlansoprazole (INN/USAN)
            Drug groups [BR:br08330]
             Gastrointestinal agent
              DG01975  Agents for peptic ulcer
               DG01646  Proton pump inhibitor (PPI)
                D08903  Dexlansoprazole
             Metabolizing enzyme substrate
              DG01639  CYP2C19 substrate
               D08903  Dexlansoprazole
              DG01633  CYP3A/CYP3A4 substrate
               DG02913  CYP3A4 substrate
                D08903  Dexlansoprazole
             Metabolizing enzyme inhibitor
              DG01933  CYP2C19 inhibitor
               D08903  Dexlansoprazole
            Drug classes [BR:br08332]
             Gastrointestinal agent
              DG01646  Proton pump inhibitor (PPI)
               D08903  Dexlansoprazole
            Target-based classification of drugs [BR:br08310]
             Enzymes
              Hydrolases (EC3)
               ATPase
                ATP4
                 D08903  Dexlansoprazole (INN/USAN) &lt;US&gt;
            Drug metabolizing enzymes and transporters [br08309.html]
             Drug metabolizing enzymes
              D08903
            Pharmacogenomic biomarkers [br08341.html]
             Polymorphisms and mutations affecting drug response
              D08903
DBLINKS     CAS: 138530-94-6
            PubChem: 96025586
            LigandBox: D08903
ATOM        25
            1   C8x C     8.1200  -19.9500
            2   C8x C     8.1200  -21.3500
            3   C8x C     9.3324  -22.0500
            4   C8y C    10.5449  -21.3500
            5   C8y C    10.5449  -19.9500
            6   C8x C     9.3324  -19.2500
            7   N5x N    11.8764  -21.7826
            8   C8y C    12.6993  -20.6500
            9   N4x N    11.8764  -19.5174
            10  S4a S    14.0700  -20.6500
            11  C1b C    14.7700  -21.8624
            12  O3c O    14.7700  -19.4376
            13  C8y C    16.1698  -21.8624
            14  C8y C    16.8603  -23.0580
            15  C8y C    18.2603  -23.0578
            16  C8x C    18.9601  -21.8453
            17  C8x C    18.2697  -20.6498
            18  N5x N    16.8697  -20.6499
            19  C1a C    16.1749  -24.2452
            20  O2a O    18.9510  -24.2532
            21  C1b C    20.3696  -24.2532
            22  C1d C    21.0556  -25.4406
            23  X   F    21.7556  -26.6531
            24  X   F    22.2680  -24.7406
            25  X   F    19.8432  -26.1406
BOND        27
            1     1   2 2
            2     2   3 1
            3     3   4 2
            4     4   5 1
            5     5   6 2
            6     1   6 1
            7     4   7 1
            8     7   8 2
            9     8   9 1
            10    5   9 1
            11    8  10 1
            12   10  11 1 #Down
            13   10  12 2
            14   11  13 1
            15   13  14 2
            16   14  15 1
            17   15  16 2
            18   16  17 1
            19   17  18 2
            20   13  18 1
            21   14  19 1
            22   15  20 1
            23   20  21 1
            24   21  22 1
            25   22  23 1
            26   22  24 1
            27   22  25 1
///
